Clinical trial · Interventional
The Diagnostic Value of PET/MRI in Head and Neck Cancer
The Diagnostic Value of 18F-2-fluoro-2-deoxy-D-glucose Fluorodeoxyglucose-Positron-Emission-Tomography/Magnetic-Resonance Imaging (PET/MRI) for Cervical Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma
NCT04117139CI-TRIAL-00041050unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study investigates the diagnostic value of PET/MRI for cervical lymph node metastases from head and neck squamous cell carcinomas.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Neoplasms | Head and Neck Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Lymph Node Metastases | — | UNRESOLVED | — |
| Squamous Cell Carcinoma of Head and Neck | Head and Neck Squamous Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| PET/MRI | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Study Group
- description
- In addition to other standard imaging modalities in the fast track cancer program, included patients will have a PET/MRI done.
- interventionNames
- Diagnostic Test: PET/MRI
Primary outcomes (1)
- measure
- Diagnostic Accuracy of PET/MRI for Malignancy in Regional Lymph Nodes
- timeFrame
- 7-10 days
- description
- PET/MRI scans are compared to histology as the golden standard to determine the diagnostic accuracy of PET/MRI for malignancy in regional lymph nodes
Secondary outcomes (1)
- measure
- Diagnostic Accuracy of PET/MRI for Extracapsular Lymph Node Spread
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Patients either suspected of or with histologically verified: * Relapse of head and neck squamous cell cancer with involvement of regional lymph node(s) * Cervical lymph node metastasis with unknown primary tumor site * Oral cavity squamous cell carcinoma * Oropharyngeal squamous cell cancer planned for trans oral robotic surgery Exclusion Criteria: * Patients who cannot have a PET/MRI performed for different reasons (allergy, claustrophobia, medical implants) * Patients who had surgery, infection or other inflammatory inducing conditions on the neck within the last 8 weeks
References
Publications (0)
Data not yet available
No reference posted for this study.